Study On Nurses' Knowledge Regarding Some Medications Induce Congenital Malformations During Pregnancy
Studi Pengetahuan Perawat Mengenai Beberapa Obat yang Menyebabkan Cacat Bawaan Selama Kehamilan
DOI:
https://doi.org/10.21070/ijhsm.v2i2.106Keywords:
Birth defects, , Pregnancy medications, , Nurse knowledge, Basra hospitals, Congenital malformationsAbstract
Many of the medications used to treat psychological illnesses, antibiotics, and other treatments for pregnant women later appear to have negative effects on the fetus during pregnancy or birth, and some of them appear after different age periods. The current study aims to familiarize nurses with these medications because of their major role in preparing and administering medications, drug doses, and medication administration periods. Female and male nurses with different academic levels and years of experience in different hospital departments participated in the questionnaire for a group of medications that cause birth defects. Most Participants have knowledge that induces birth defects or malformation during pregnancy especially medicines that are commonly used, also knowledge may correlate with their academic level or experience
Highlights:
- Nurses' knowledge of drugs causing birth defects during pregnancy.
- Awareness varies by academic level and work experience.
- Emphasizes nurses' role in safe medication administration.
Keywords: Birth defects, Pregnancy medications, Nurse knowledge, Basra hospitals, Congenital malformations
References
[1] M. De Santis, B. Carducci, A. F. Cavaliere, L. De Santis, G. Straface, and A. Caruso, "Drug-Induced Congenital Defects: Strategies to Reduce the Incidence," Drug safety, vol. 24, pp. 889-901, 2001.
[2] G. G. Briggs and R. K. Freeman, Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk: Lippincott Williams & Wilkins, 2014.
[3] M. De Santis, G. Straface, B. Carducci, A. F. Cavaliere, L. De Santis, A. Lucchese, et al., "Risk of drug-induced congenital defects," European Journal of Obstetrics & Gynecology and Reproductive Biology, vol. 117, pp. 10-19, 2004.
[4] M. Barr, "Fetal effects of angiotensin-converting enzyme inhibitor," Teratology, vol. 41, p. 536, 1990.
[5] J. M. Piper, W. A. RAY, and F. W. ROSA, "Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors," Obstetrics & Gynecology, vol. 80, pp. 429-432, 1992.
[6] T. Tomson, L. Sha, and L. Chen, "Management of epilepsy in pregnancy: what we still need to learn," Epilepsy & Behavior Reports, vol. 24, p. 100624, 2023.
[7] P. B. Bookstaver, C. M. Bland, B. Griffin, K. R. Stover, L. S. Eiland, and M. McLaughlin, "A review of antibiotic use in pregnancy," Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, vol. 35, pp. 1052-1062, 2015.
[8] A. H. Piersma, E. V. Hessel, and Y. C. Staal, "Retinoic acid in developmental toxicology: teratogen, morphogen, and biomarker," Reproductive toxicology, vol. 72, pp. 53-61, 2017.
[9] M. M. Van Gelder, I. A. Van Rooij, R. K. Miller, G. A. Zielhuis, L. T. de Jong-van den Berg, and N. Roeleveld, "Teratogenic mechanisms of medical drugs," Human reproduction update, vol. 16, pp. 378-394, 2010.
[10] G. Kanayama and H. G. Pope Jr, "Illicit use of androgens and other hormones: recent advances," Current Opinion in Endocrinology, Diabetes, and Obesity, vol. 19, pp. 211-219, 2012.
[11] G. Alem, M. Awuonda, D. Haastrup, A. Anyiwo, M. Daftary, and E. Ettienne, "Evaluation of knowledge of the new Pregnancy and Lactation Labeling Rule among pharmacists and physicians," Journal of the American Pharmacists Association, vol. 62, pp. 427-431, 2022.
[12] E. S. Tsamantioti and M. F. Hashmi, "Teratogenic medications," in StatPearls [Internet], ed: StatPearls Publishing, 2024.
[13] R. L. Bromley, J. Weston, and A. G. Marson, "Maternal use of antiepileptic agents during pregnancy and major congenital malformations in children," Jama, vol. 318, pp. 1700-1701, 2017.
[14] N. C. Momen, A. Ernst, L. H. Arendt, J. Olsen, J. Li, M. Gissler, et al., "Maternal cancer and congenital anomalies in children–a Danish nationwide cohort study," PLoS One, vol. 12, p. e0173355, 2017.
[15] L. Storgaard, J. P. Bonde, and J. Olsen, "Male reproductive disorders in humans and prenatal indicators of estrogen exposure: a review of published epidemiological studies," Reproductive Toxicology, vol. 21, pp. 4-15, 2006.
[16] A. M. Tiryag and H. H. Atiyah, "Nurses' knowledge toward obesity in al-Basra city," Annals of the Romanian Society for Cell Biology, pp. 4667-4673, 2021.
[17] A. M. Tiryag and H. H. Atiyah, "Nurses’ Knowledge toward Bariatric Surgery at Surgical Wards at Teaching Hospitals in Al-Basra City," Indian Journal of Forensic Medicine & Toxicology, vol. 15, pp. 5152-5159, 2021.
[18] H. H. Abdul-Ra’aoof, S. B. Dawood, F. A. Jassim, S. K. Jassim, S. S. Issa, A. M. Tiryag, et al., "Moderate proficiency in suture techniques among nurses: A cross-sectional study," Academia Open, vol. 9, 2024.
[19] H. H. Abdul-Ra’aoof, A. M. Tiryag, and M. A. Atiyah, "Knowledge, attitudes, and practice of nursing students about insulin therapy: A cross-sectional study," Academia Open, vol. 9, pp. 10.21070/acopen. 9.2024. 8795-10.21070/acopen. 9.2024. 8795, 2024.
[20] A. Tiryag, M. Atiyah, and A. Khudhair, "Nurses' Knowledge and Attitudes toward Thyroidectomy: A Cross-Sectional Study," Health Education and Health Promotion, vol. 10, pp. 459-465, 2022.
[21] H. H. Abdul-Ra’aoof, M. A. Akber, F. A. Jassim, A. M. Tiryag, S. S. Issa, M. A. Atiyah, et al., "The Psychological Impact of Violence on Emergency Department and Intensive Care Unit Nurses: A Cross-Sectional Study," Research Journal of Trauma and Disability Studies, vol. 3, pp. 228-233, 2024.
[22] A. M. Tiryag, "Revitalizing Hearts: The Transformative Impact of Pacemaker Therapy on Cardiac Conduction Disorders," Academia Open, vol. 9, pp. 10.21070/acopen. 9.2024. 8845-10.21070/acopen. 9.2024. 8845, 2024.
[23] E. H. Rahi, Z. M. H. Al-Hejaj, and A. M. Tiryag, "Nurses' knowledge of nonalcoholic fatty liver disease: A cross-sectional study," Academia Open, vol. 9, pp. 10.21070/acopen. 9.2024. 10306-10.21070/acopen. 9.2024. 10306, 2024.
[24] H. M. Sabty, S. B. Dawood, and A. M. Tiryag, "Nurses’ knowledge and practices on influenza vaccination for pregnant women," Jurnal Kebidanan Midwiferia, vol. 10, pp. 50-59, 2024.
[25] A. M. Tiryag, S. B. Dawood, and S. K. Jassim, "Nurses’ knowledge and attitudes about enteral feeding complications by nasogastric tube in intensive care units," Rawal Medical Journal, vol. 48, pp. 689-689, 2023.
[26] M. A. Akber, A. M. Tiryag, and A. I. H. Alobaidi, "Nurses’ Knowledge Regarding Cast Complications of Limb Fractures: A Cross-Sectional Study," Central Asian Journal of Medical and Natural Science, vol. 5, pp. 195-200, 2024.
[27] M. A. Akber, A. M. Tiryag, and A. Alobaidi, "Nurses’ knowledge concerning developmental dysplasia of the hip: A cross-sectional study," American Journal of Pediatric Medicine and Health Sciences, vol. 2, pp. 155-160, 2024.
[28] A. A. A. Al-Iedan, M. A. Akber, S. B. Dawood, A. I. H. Alobaidi, S. S. Issa, H. H. A. Raaoof, et al., "Bridging the Gap: Enhancing Open Fracture Care in Emergency Nursing," Academia Open, vol. 9, pp. 10.21070/acopen. 9.2024. 8847-10.21070/acopen. 9.2024. 8847, 2024.
[29] Z. S. Dawood, K. M. Jassim, A. M. Tiryag, and A. S. Khudhair, "Nurses' Knowledge and Attitudes Toward Deep Vein Thrombosis: A Cross-Sectional Study," Bahrain Medical Bulletin, vol. 45, 2023.
[30] K. M. Jassim, A. S. Khudhair, Z. S. Dawood, and A. M. Tiryag, "Nurses’ knowledge about electrocardiogram interpretation: A cross-sectional study," Rawal Medical Journal, vol. 48, pp. 850-850, 2023.
[31] M. F. Hasan, W. F. Hussein, A. M. Tiryag, I. J. Ali, and Z. M. Shaker, "Nurses’ knowledge toward lower back pain: A cross-sectional study," Academia Open, vol. 9, pp. 10.21070/acopen. 9.2024. 10363-10.21070/acopen. 9.2024. 10363, 2024.
[32] A. M. Tiryag, "Nurses’ Knowledge and Attitudes Toward Pacemaker: A Cross-Sectional Study," Academia Open, vol. 9, pp. 10.21070/acopen. 9.2024. 8845-10.21070/acopen. 9.2024. 8845, 2024.
[33] N. Vargesson, "Thalidomide‐induced limb defects: resolving a 50‐year‐old puzzle," Bioessays, vol. 31, pp. 1327-1336, 2009.
[34] T. W. Kowalski, J. d. A. Gomes, G. B. C. Garcia, L. R. Fraga, V. R. Paixao-Cortes, M. Recamonde-Mendoza, et al., "CRL4-Cereblon complex in Thalidomide Embryopathy: a translational investigation," Scientific Reports, vol. 10, p. 851, 2020.
[35] C. Therapontos, L. Erskine, E. R. Gardner, W. D. Figg, and N. Vargesson, "Thalidomide induces limb defects by preventing angiogenic outgrowth during early limb formation," Proceedings of the National Academy of Sciences, vol. 106, pp. 8573-8578, 2009.
[36] W. M. Weikum, U. Brain, C. M. Chau, R. E. Grunau, W. T. Boyce, A. Diamond, et al., "Prenatal serotonin reuptake inhibitor (SRI) antidepressant exposure and serotonin transporter promoter genotype (SLC6A4) influence executive functions at 6 years of age," Frontiers in cellular neuroscience, vol. 7, p. 180, 2013.
[37] M. H. d. C. Chagas, H. Flores, F. d. A. C. Campos, R. A. d. Santana, and E. C. B. Lins, "Teratogenia da vitamina A," Revista Brasileira de Saúde Materno Infantil, vol. 3, pp. 247-252, 2003.
[38] S. Bastos Maia, A. S. Rolland Souza, M. d. F. Costa Caminha, S. Lins da Silva, R. d. S. B. L. Callou Cruz, C. Carvalho dos Santos, et al., "Vitamin A and pregnancy: a narrative review," Nutrients, vol. 11, p. 681, 2019.
[39] H. Dolk, M. Loane, and E. Garne, "The prevalence of congenital anomalies in Europe," Rare diseases epidemiology, pp. 349-364, 2010.
[40] W. H. Organization, WHO recommendations on antenatal care for a positive pregnancy experience: World Health Organization, 2016.
